Codex logo

Codex Funding & Investors

Codex DNA is a pioneer in synthetic Biology. We’ve commercialized the world's first fully automated biologics printer. It harnesses the power and precision of the Gibson Assembly® method to synthesize genes in a single overnight operation on the benchtop. Our vision is to bridge the gap between the digital and biological worlds by developing revolutionary synthetic genomics platforms that accelerate advances in drug discovery, precision medicine, DNA data storage, and industrial design.

codexdna.com

Total Amount Raised: $99,200,000

Codex Funding Rounds

  • Post Ipo Equity

    $74,200,000

    Post Ipo Equity Investors

    Novalis LifeSciences
    BroadOak Capital Partners
    M-185 Corporation
    Northpond Ventures
  • Series A

    $25,000,000

    Series A Investors

    Oxford Finance
    BroadOak Capital Partners
    Northpond Ventures
Funding info provided by Diffbot.